Intraductal oncocytic papillary and intraductal tubulopapillary neoplasms are distinguished from intraductal papillary mucinous neoplasms and ductal adenocarcinoma by the absence of KRAS in these lesions. This evidence concerns the gene KRAS and pancreatic intraductal papillary-mucinous neoplasm.